232 related articles for article (PubMed ID: 33430962)
21. Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis.
Chouri E; Servaas NH; Bekker CPJ; Affandi AJ; Cossu M; Hillen MR; Angiolilli C; Mertens JS; van den Hoogen LL; Silva-Cardoso S; van der Kroef M; Vazirpanah N; Wichers CGK; Carvalheiro T; Blokland SLM; Giovannone B; Porretti L; Marut W; Vigone B; van Roon JAG; Beretta L; Rossato M; Radstake TRDJ
J Autoimmun; 2018 May; 89():162-170. PubMed ID: 29371048
[TBL] [Abstract][Full Text] [Related]
22. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
Khanna D; Tashkin DP; Denton CP; Renzoni EA; Desai SR; Varga J
Am J Respir Crit Care Med; 2020 Mar; 201(6):650-660. PubMed ID: 31841044
[TBL] [Abstract][Full Text] [Related]
23. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3.
Honda N; Jinnin M; Kira-Etoh T; Makino K; Kajihara I; Makino T; Fukushima S; Inoue Y; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
Am J Pathol; 2013 Jan; 182(1):206-16. PubMed ID: 23159943
[TBL] [Abstract][Full Text] [Related]
24. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis.
Zhang L; Zheng D; Yan Y; Yu Y; Chen R; Li Z; Greer PA; Peng T; Wang Q
Arthritis Res Ther; 2022 Jun; 24(1):148. PubMed ID: 35729674
[TBL] [Abstract][Full Text] [Related]
25. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma.
Makino K; Jinnin M; Hirano A; Yamane K; Eto M; Kusano T; Honda N; Kajihara I; Makino T; Sakai K; Masuguchi S; Fukushima S; Ihn H
J Immunol; 2013 Apr; 190(8):3905-15. PubMed ID: 23509348
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1.
Zhou B; Zhu H; Luo H; Gao S; Dai X; Li Y; Zuo X
Biomed Pharmacother; 2017 Mar; 87():412-418. PubMed ID: 28068631
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis-Associated Interstitial Lung Disease.
Papazoglou A; Huang M; Bulik M; Lafyatis A; Tabib T; Morse C; Sembrat J; Rojas M; Valenzi E; Lafyatis R
Arthritis Rheumatol; 2022 Dec; 74(12):2003-2014. PubMed ID: 35849803
[TBL] [Abstract][Full Text] [Related]
28. Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis.
Artlett CM; Sassi-Gaha S; Hope JL; Feghali-Bostwick CA; Katsikis PD
Arthritis Res Ther; 2017 Jun; 19(1):144. PubMed ID: 28623945
[TBL] [Abstract][Full Text] [Related]
29. Overexpressed microRNA-140 inhibits pulmonary fibrosis in interstitial lung disease via the Wnt signaling pathway by downregulating osteoglycin.
Shi S; Li H
Am J Physiol Cell Physiol; 2020 Nov; 319(5):C895-C905. PubMed ID: 32755451
[TBL] [Abstract][Full Text] [Related]
30. Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.
Mendoza FA; Piera-Velazquez S; Farber JL; Feghali-Bostwick C; Jiménez SA
Arthritis Rheumatol; 2016 Jan; 68(1):210-7. PubMed ID: 26360820
[TBL] [Abstract][Full Text] [Related]
31. Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.
Lindahl GE; Stock CJ; Shi-Wen X; Leoni P; Sestini P; Howat SL; Bou-Gharios G; Nicholson AG; Denton CP; Grutters JC; Maher TM; Wells AU; Abraham DJ; Renzoni EA
Respir Res; 2013 Aug; 14(1):80. PubMed ID: 23915349
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of TNF-induced protein 3 and CCAAT/enhancer-binding protein β in alveolar macrophages: Implications for systemic sclerosis-associated interstitial lung disease.
Hua X; Hongbing R; Juan X; Jizan L; Beibei Y
Int J Rheum Dis; 2024 May; 27(5):e15174. PubMed ID: 38720423
[TBL] [Abstract][Full Text] [Related]
33. Identification of Potential ceRNA Network and Patterns of Immune Cell Infiltration in Systemic Sclerosis-Associated Interstitial Lung Disease.
Wu Q; Liu Y; Xie Y; Wei S; Liu Y
Front Cell Dev Biol; 2021; 9():622021. PubMed ID: 34222222
[TBL] [Abstract][Full Text] [Related]
34. Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease.
Yang MM; Lee S; Neely J; Hinchcliff M; Wolters PJ; Sirota M
Front Immunol; 2024; 15():1326922. PubMed ID: 38348044
[TBL] [Abstract][Full Text] [Related]
35. Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis.
Liu S; Chung MP; Ley B; French S; Elicker BM; Fiorentino DF; Chung LS; Boin F; Wolters PJ
Thorax; 2021 Dec; 76(12):1186-1192. PubMed ID: 34272332
[TBL] [Abstract][Full Text] [Related]
36. Association of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis.
Christmann RB; Sampaio-Barros P; Stifano G; Borges CL; de Carvalho CR; Kairalla R; Parra ER; Spira A; Simms R; Capellozzi VL; Lafyatis R
Arthritis Rheumatol; 2014 Mar; 66(3):714-25. PubMed ID: 24574232
[TBL] [Abstract][Full Text] [Related]
37. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
Jimenez SA; Piera-Velazquez S
Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
[TBL] [Abstract][Full Text] [Related]
38. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
[TBL] [Abstract][Full Text] [Related]
39. Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease.
Odani T; Yasuda S; Ota Y; Fujieda Y; Kon Y; Horita T; Kawaguchi Y; Atsumi T; Yamanaka H; Koike T
Rheumatology (Oxford); 2012 Oct; 51(10):1765-74. PubMed ID: 22723597
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of interferon regulated and antiviral response genes in CD31+/CD102+ lung microvascular endothelial cells from systemic sclerosis patients with end-stage interstitial lung disease.
Piera-Velazquez S; Mendoza FA; Addya S; Pomante D; Jimenez SA
Clin Exp Rheumatol; 2021; 39(6):1298-1306. PubMed ID: 33253099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]